Viña, Analyn T.

HRN: 21-41-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2022
CEFUROXIME 500MG (TAB)
05/31/2022
06/07/2022
IVT
500mg/tab
BID
Post NSVD; Thickly MSAF
Waiting Final Action 
05/31/2022
METRONIDAZOLE 500MG (TAB)
05/31/2022
06/07/2022
IVT
500mg/tab
TID
Post NSVD; Thickly MSAF
Waiting Final Action 
05/31/2022
CEFUROXIME 1.5GM (VIAL)
05/31/2022
06/07/2022
IV
1.5g
Q8
UTI; Thickly MSAF; G4P4
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: